Friday, October 30, 2026

Regeneron (REGN) Q3 FY 12/26 Earnings Review

Regeneron’s Q3 revenue rose 36% to $5.1 billion, driven by a 68% jump in Sanofi collaboration revenue, while operating income doubled to $2.0 billion.

REGN $84B

Cestrian Capital Research Oct 30 2 clicks

Oct 30 BE $67B

Bloom: Chinese Scandium Supply Route Restarts

Hunterbrook 4 clicks

Oct 30 MKL $23B

TSOH Weekly Roundup (10/30/2026)

TSOH Investment Research 1 click

From X

@hntrbrkmedia Oct 30

Hunterbrook on X

UPDATE: Remember when Bloom claimed its supply chain is “not dependent on China” after Hunterbrook’s reporting? New trade records show $BE seems to have quietly restarted a Chinese supply route for scandium-containing fuel cell parts. https://t.co/BUAGun5iAR

@gnoble79 Oct 30

George Noble on X

SHORT $OKLO SHORT $CRWV SHORT $ALAB ALL GARBAGE https://t.co/95dcdvQsly

@StableBread Oct 30

Fajasy on X

If First Solar $FSLR wins its patent case at the U.S. International Trade Commission (ITC), TOYO Co., Ltd’s $TOYO cells could be barred from the U.S. First Solar filed a complaint at the ITC on February 24, 2026, claiming certain TOPCon cells, a common high-efficiency silicon cell design, infringe one of its patents. The ITC voted on March 26 to open Investigation 337-TA-1494, naming $TOYO, its Texas subsidiary, VSUN (the Vietnamese panel maker $TOYO was carved out of), and VSUN’s U.S. arm among 47 respondents. The ITC’s target date is November 15, 2027. The patent case won’t be decided before late 2027, but it’s another way $TOYO’s cells could be stopped at the border. I’m not worried about the patent case yet, since the ITC’s target date is more than a year away and dozens of other respondents face the same claim.

@finphysnerd Oct 30 1 click

Myles on X

$RDDT was a big mistake and loss for me, but was a win in how my framework for position sizing has improved over time. I think a year or two ago I would have sized up after the earlier dip and gotten wrecked here but I think I've improved at recognising risk and sizing

@hkuppy Oct 30

Kuppy on X

@roojoo3 Check the $SCI numbers. They literally cannot afford to die anymore… sad…

@Mr_Neutral_Man Oct 29 1 click

Mr Neutral Man aka "Howard Marks of REITs” on X

@TimelessArie Ticker is $INVH for those curious

@BarbarianCap Oct 29

Barbarian Capital on X

Roblox Narrows Loss as User, Engagement Metrics Fall The video-game company said average daily users were down 9% to 138 million, and engagement hours fell 15% to 34 billion. $RBLX https://t.co/KQM4qbpsbd

@ACapitalLP Oct 29

A Capital on X

$FSLR interesting here at ~7–8x 2027 earnings with 44GW of contracted backlog. Q3 bookings at ~$0.36/W were largely negotiated pre-232, while management is already quoting higher prices on new business. Think the first meaningful post-232 contracts will be particularly informative as to normalized earnings power and ultimately where this should trade…

Wall Street Erased $16 Billion From a Legal Monopoly Over an AI Myth.

Verisk Analytics’ 40 petabytes of proprietary insurance data and regulatory infrastructure shield its underwriting business from generative…

VRSK $26B

First Strike Research Oct 30 7 clicks

What a Marvell-Lumentum Deal Means for DSPs, Lasers, and Modules

Marvell’s reported Lumentum bid would combine DSPs, lasers and optical modules, but $4 billion of cash and $5 billion of debt point to a…

LITE $83B

Vik's Newsletter Oct 30 1 click

Another Haircut with Avy the Barber

SoFi’s stock case hinges on interest rates, tangible book value and private-credit loan sales after its $1.5 billion equity offering.

SOFI $22B

WHAT ARE WE DOING? “Contrarians At The Gate” Oct 29 3 clicks

Twilio CEO: ‘Buy the dip!’

Twilio CEO Khozema Shipchandler urged investors to “buy the dip” after earnings sent the software maker’s shares down 17% after hours.

TWLO $39B

The Technology Letter Oct 29 2 clicks

Incyte (INCY) Q3 FY 12/26 Earnings Review

Incyte reported Q3 FY26 revenue of $1.56 billion, up 14%, while a $1.23 billion Vega acquisition charge drove a $708 million operating loss.

INCY $24B

Cestrian Capital Research Oct 29 2 clicks

CoStar: 3Q26 Business Recap

CoStar’s 3Q26 revenue growth slowed to 14% as bookings fell to $37 million, while cost cuts lifted EBIT margin to 8.8%.

CSGP $12B

Speedwell Memos Oct 29 3 clicks

Carpenter Technology (CRS) Q1'27: The Sell-Off Resets the Entry Point

Carpenter Technology fell 25% after Q1 2027 despite revenue rising 9%, EPS up 34%, and commercial aerospace bookings up 25%.

CRS $15B

Monte Independent Investment Research Oct 29 3 clicks

[scuttleslops] GOOGL, AMZN, BRO, KNSL, ODFL, MCO, SPGI

Google’s AI search could improve ad economics, while Amazon protects its retail ad funnel from shopping agents and specialty insurers face…

BRO $23B

scuttleblurb Oct 29 1 click

This Week in Special Situations: Mattel, Winnebago, PayPal

Mattel, Winnebago and PayPal lead 37 special situations spanning activist campaigns, buybacks, M&A and strategic alternatives.

PYPL $47B

Latticework by MOI Global Oct 29 2 clicks

Nebius: Why I Loaded Up During This Crash

Nebius secured $4.275 billion in credit facilities and trades at 3.8 times projected 2027 sales, with an AI credit crunch its main…

NBIS $46B

Infinity Curve Oct 29

Culper Research vs Cerebras: A Neutral Engineering-Driven View

Cerebras’ alleged electromigration issues hinge on temperature and voltage limits, not total power draw, while thermal variation and…

CBRS $27B

Irrational Analysis Oct 28 3 clicks

CoStar 3Q26 Recap: Cost Decreases Cost of Growth

CoStar’s 14% revenue growth, $37 million in net new bookings and 14% stock drop sharpen doubts that sales and marketing cuts can coexist…

CSGP $12B

Speedwell Research Oct 28 1 click

Group 1 Automotive (GPI): Q3 2026 Earnings

Group 1 Automotive trades at 5.5 times earnings as aging gasoline vehicles and EV repairs sustain service profits; insiders bought while…

PAG $14B

Cannibal Stocks Oct 28 1 click

Cerebras ($CBRS): A Neocloud Masquerading as a Chipmaker

Cerebras relies on OpenAI for almost all of its $25 billion backlog while renting AI capacity, raising questions over its semiconductor…

CBRS $27B

Shallow Dives Oct 28 4 clicks

The Cigna Group: Client Retention Matters, But Contract Profitability Matters More

Cigna faces PBM margin pressure as employer fee demands and Signature transition costs outweigh specialty-drug growth, limiting profit…

CI $78B

Narek Hovhannisyan Oct 28 1 click

Vertiv (NYSE: VRT) Stock Rating: Accumulate, $329 Price Target After Q3 FY12/26 Earnings

Vertiv beat Q3 revenue guidance by $460 million, grew organic sales 55%, and raised full-year revenue guidance by $650 million to a $14.65…

VRT $88B

Cestrian Capital Research Oct 28 3 clicks

EQT Q3 FY12/26 Earnings Review - Distribute Rating

EQT moved to Distribute at $56.29 after Q3 revenue fell 9.6%; a 44% trailing free-cash-flow margin signals cycle risk despite lower debt…

EQT $34B

Cestrian Capital Research Oct 27 2 clicks

Innodata responds, Amkor surges, Mega Tech spending on tap

Innodata shares fell 25% to $44.74 after India Today reported 550 job cuts in India.

AMKR $10B

The Technology Letter Oct 27 6 clicks

My Last GFL Update - Hopefully

GFL’s take-private structure hinges on BC Partners rolling 60% of its stake to preserve debt portability under the 40% permitted-holder…

GFL $16B

310 Value’s Newsletter Oct 27 5 clicks

Expert Call | Lumentum Optical Chip Capacity, EML/SiPh Outlook & Industry Pricing

Lumentum’s 2027 optical-chip expansion, 200G EML and CW capacity, silicon-photonics roadmap, pricing and 3.2T module prospects face…

LITE $83B

P Equity Research Oct 27 2 clicks

Friday, October 30, 2026

Hunterbrook on X

George Noble on X

Fajasy on X

Myles on X

Kuppy on X

Mr Neutral Man aka "Howard Marks of REITs” on X

Barbarian Capital on X

A Capital on X

Investor Letters

Publications we follow

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 67 of 266

X accounts we follow

Investor letters we follow

Sectors